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Abstract
Background: Neonatal sepsis is a significant cause of morbidity and mortality in neonates. Appropriate clinical 
diagnosis and empirical treatment in a given setting is crucial as pathogens of bacterial sepsis and antibiotic sensitivity 
pattern can considerably vary in different settings. This study was conducted at Bugando Medical Centre (BMC), 
Tanzania to determine the prevalence of neonatal sepsis, predictors of positive blood culture, deaths and antimicrobial 
susceptibility, thus providing essential information to formulate a policy for management of neonatal sepsis.
Methods: This was a prospective cross sectional study involving 300 neonates admitted at BMC neonatal unit 
between March and November 2009. Standard data collection form was used to collect all demographic data and 
clinical characteristics of neonates. Blood culture was done on Brain Heart Infusion broth followed by identification of 
isolates using conventional methods and testing for their susceptibility to antimicrobial agents using the disc diffusion 
method.
Results: Among 770 neonates admitted during the study period; 300 (38.9%) neonates were diagnosed to have 
neonatal sepsis by WHO criteria. Of 300 neonates with clinical neonatal sepsis 121(40%) and 179(60%) had early and 
late onset sepsis respectively. Positive blood culture was found in 57 (47.1%) and 92 (51.4%) among neonates with early 
and late onset neonatal sepsis respectively (p = 0.466). Predictors of positive blood culture in both early and late onset 
neonatal sepsis were inability to feed, lethargy, cyanosis, meconium stained liquor, premature rupture of the 
membrane and convulsion. About 49% of gram negatives isolates were resistant to third generation cephalosporins 
and 28% of Staphylococcus aureus were found to be Methicillin resistant Staphylococcus aureus (MRSA). Deaths occurred 
in 57 (19%) of neonates. Factors that predicted deaths were positive blood culture (p = 0.0001), gram negative sepsis (p 
= 0.0001) and infection with ESBL (p = 0.008) or MRSA (p = 0.008) isolates.
Conclusion: Our findings suggest that lethargy, convulsion, inability to feed, cyanosis, PROM and meconium stained 
liquor are significantly associated with positive blood culture in both early and late onset disease. Mortality and 
morbidity on neonatal sepsis is high at our setting and is significantly contributed by positive blood culture with multi-
resistant gram negative bacteria.
Background
World Health Organization (WHO) estimates about 5
million neonatal deaths a year. Almost all deaths occur in
developing countries; half of them in the African region
[1]. Septicemia is a common cause of infants' morbidity
and mortality in developing countries [1]. There is no
pathognmonic features of neonatal sepsis [2]; clinical pre-
sentation of neonatal sepsis can vary; in most studies
symptoms include fever, difficult in breathing, tachycar-
dia, malaise, difficult in feeding and lethargy [1,3,4]. It is
therefore important to carry out investigation to confirm
neonatal sepsis in the setting of good laboratory facilities
and services. In the study done in Kenya, difficult in feed-
ing, unexplained pallor, cyanosis and unconsciousness
were strongly associated with severe sepsis while fast
breathing, nasal flaring, grunting and lethargy were found
to be associated with moderate form of sepsis [5]. WHO
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has made criteria for initial diagnosis of neonatal sepsis,
but the sensitivity and specificity of clinical diagnosis can
vary considerably [1,2,6].
Prompt diagnosis and effective treatment is necessary
to prevent deaths and complications due to septicemia.
Physical signs and symptoms are useful in identifying
infants and children with septicemia. These clinical char-
acteristics can be good predictors for positive blood cul-
ture but they have limited specificity and sensitivity [7. 8].
Neonatal blood culture positive rate have been found to
range from 25-54% [5,9-11]. Rapid immunological tech-
niques like C-Reactive Proteins (CRP) assays may help in
the diagnosis of septicemia; however they lack the capac-
ity to detect specific pathogens and are not available in
many centers in developing countries [12]. Blood culture
to isolate the offending pathogen remains the gold stan-
dard for definitive diagnosis of septicemia [1,12] but the
results of blood culture takes hours to days, thus necessi-
tating initial empirical treatment of suspected cases.
Knowledge of predictors of positive blood culture and
anti-microbial susceptibility pattern of common patho-
gens in a given area is essential in guiding local empirical
choice of antibiotics [12].
At Bugando Medical Centre (BMC) neonatal units'
ampicillin and gentamicin are used as the first line empir-
ical treatment, the decision of this regimen is based on
research in different units in developed countries. The
antimicrobial susceptibility may vary between units and
there is increasing resistance rate of gram negative bacte-
ria to ampicillin gentamicin and cefotaxime worldwide;
this warrants the availability of local data [13].
In Tanzania, as in other Sub-Saharan countries the epi-
demiology of neonatal sepsis has not been extensively
studied and therefore to date most of empirical treat-
ments have been formulated using data from developed
countries [1,5]. Thus this study was done to determine
the pattern of neonatal sepsis and the outcome at BMC,
Mwanza Tanzania in order to generate local data that will
be used for local policy formulation in managing neonatal
sepsis. The predictors of positive blood culture and
deaths established in the present study are useful to Pedi-
atricians locally and in other centers for aggressive man-
agement of neonatal sepsis.
Methods
Study design and setting
This was a hospital based prospective cross-sectional
study conducted at Bugando Medical centre (BMC) neo-
natal unit from March to November 2009. BMC is a ter-
tiary facility which handles referrals from peripherals in
the Lake zone of Tanzania; it serves 13 million Tanzani-
ans.
Study population
Sample size was calculated using Kish and Lisle methods,
using P of 20% about 300 neonates were targeted [14].
During the study period 770 neonates were admitted in
the unit and assessed using WHO sepsis screening tool
and 300 neonates with clinical neonatal sepsis and had a
bl ood cul t ur e  dr a wn we r e  inc l uded in t he  ana l ys is  [ 6].
These neonates included those delivered at BMC and
referral from other centers in the Lake Zone.
Data collection
Using guidelines laid down by WHO young Infant Study
Group [6] a standard structured data collection form was
designed to obtain social demographic data and other rel-
evant information such as maternal fever, premature rup-
ture of membranes (PROM) weight of the baby,
gestational age, temperature of the infant, respiration
rate, mode of delivery, presence or absence of cyanosis,
jaundice, umbilical redness, convulsion, reduced move-
ment and ability to feed. Appropriate treatment was initi-
ated after collection of blood and neonates were followed
until discharge or death; hospital stay to discharge or
deaths was recorded in days.
Blood culture
Using aseptic technique about 2 ml-5 ml of blood was
obtained and inoculated directly into Brain Heart Infu-
sion broth (BHI) (Oxoid Ltd, UK) in a ratio of blood: BHI
of 1:10 and transported to the WBUCHS Microbiology
laboratory for incubation and subsequent processing.
Lab procedures
Aerobic Blood culture was done; after 24 hrs incubation
gram stain was done followed by blind subculture on 5%
sheep blood agar, chocolate agar, MacConkey agar and
MacConkey with 30μg/ml cefotaxime (Oxoid Ltd, UK).
Broth cultures were further re-incubated and then sub
cultured after 48 hours then after 96 hrs with last subcul-
ture on day 7. Identification of bacteria was made by con-
ventional physiological and biochemical methods. These
included gram stain, catalase reaction, coagulase reac-
tion, hemolytic activity on sheep blood agar plates, hip-
purate hydrolysis and CAMP tests for gram positive
bacteria. In case of gram negative colonies morphology
on blood and MacConkey agar, triple sugar iron agar
reaction, indole, motility, citrate, urease, hydrogen sul-
phide production and VP test were used [15].
Finally, antimicrobial susceptibility of all isolates was
determined by disk diffusion method according to Clini-
cal Laboratory Standard Institute [16]. For gram positive
bacteria discs tested included; penicillin G (10 U), ampi-
cillin (10 μg), clindamycin (2 μg), erythromycin (15 μg),
vancomycin (30 μg), ciprofloxacin (5 μg), oxacillin (5 μg)
and cefoxitin (30 μg). For gram negatives discs used wereKayange et al. BMC Pediatrics 2010, 10:39
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ampicillin (10 μg), amoxyillin/clavunate (20/10 μg), cipro-
floxacin (5 μg), tetracycline (30 μg), gentamicin (10 μg),
Sulphamethaxazole/trimethoprim (SXT)1.25/23.75 μg)
and ceftriaxone (30 μg). Other reserve discs included cef-
tazidime (30 μg), cefepime (30 μg) and meropenem (10
μg) (Oxoid UK). Isolates were screened for ESBL produc-
tion using MacConkey agar with 30 μg /ml cefotaxime
and confirmed using disc approximation method [15,16].
Data analysis
The early onset sepsis was defined as disease occurring in
≤72 hours of age and late onset sepsis that occurring
more than 72 hours of age [7]. Separate multivariable
analyses were carried out to identify risk factors associ-
ated with early and late onset sepsis. Organisms causing,
and outcomes of cases with early and late onset sepsis
were also compared. Data was analyzed using SPSS for
windows version 11.0 [17]. Statistical test between depen-
dent and independent variables was done using Chi-
squared test (χ2). Where the numbers in a cell was less
than five, a Fisher's exact test was used. P-values ≤ 0.05
were considered statistically significant. All variables with
association using univariate analysis were subjected to
multivariate analysis.
Ethical issues
Ethical clearance was obtained from BMC/WBUCHS
ethical review board and a written informed consent was
obtained from each mother/caretaker.
Results
Characteristic of study population
Three hundred neonates with clinical sepsis were
enrolled in the study between March and November
2009. This was about 39% of neonates admitted during
the study period. Early and late neonatal sepsis occurred
in 121(40%) and 179(60%) respectively (Table 1).
Culture results and susceptibility pattern
Of 300 neonates with clinical sepsis positive blood cul-
ture was found in 57(47%) and 92 (51.4%) among neo-
nates with early and late neonatal sepsis respectively.
Gram negative bacteria 91 (61.1%) were more frequently
i s o l a t e d  t h a n  g r a m  po s i t i v e  b a c t e r i a.  C o m m o n  i s o l a t e s
were Klebsiella pneumoniae, Staphylococcus aureus and
Escherichia coli. Other pathogens were Coagulase nega-
tive staphylococcus (CNS) Acinetobacter spp,  Enter-
obacter spp and other gram positive bacteria (Listeria spp,
Group B streptococci and Enterococcus spp) (Table 2).
Escherichia coli, Klebsiella pneumoniae, Enterobacter spp
and Group B streptococci were commonly recovered in
neonates from mothers with PROM. Eighty two percent
of  Klebsiella pneumoniae and 76% of Escherichia coli
were isolated from neonates delivered in hospital.
Most of Klebsiella pneumoniae and  Escherichia coli
were resistant to ampicillin and gentamicin with high
proportion of gram positive bacteria being resistant to
cloxacillin (first line treatment in the unit) (Table 2).
More than 49% of Klebsiella pneumoniae, Escherichia coli
and other gram negative bacteria were resistant to third
generation cephalosporins (ceftriaxone, cefotaxime and
ceftazidime) with majority of them being ESBL producer.
Majority of these gram negative isolates were sensitive to
ciprofloxacin and meropenem. Among 32 Staphylococcus
aureus  9 (28%) were found to be Methicillin Resistant
Staphylococcus aureus (MRSA) (i.e resistant to oxacillin
and cefoxitin) (Table 2).
Factors associated with positive blood culture and 
increased mortality in early and late neonatal sepsis
No significant difference in positive blood culture results
was observed between early and late onset sepsis. Per-
centage of neonates with early onset sepsis born at home
was 31% and that of neonates with late onset sepsis born
at home 42%. Among neonates with late onset sepsis
those delivered in hospital had higher positive blood cul-
ture rate than those delivered at home (p = 0.006) (Table
1). Perinatal factors like PROM and meconium stained
liquor were strongly associated with positive blood cul-
ture in both early and late onset sepsis (p ≤ 0.001). Gesta-
tional age and small gestational age by birthweight were
not found to influence rate of positive blood culture in
both early and late onset neonatal sepsis (Table 1). Clini-
cal characteristics which were found to be significantly
associated with positive blood culture on both univariate
and multivariate analysis in early and late onset sepsis
were inability to feed, lethargy, convulsion and cyanosis
(Table 3). Increase in respiratory rate was only found to
be a predictor of positive blood culture in early onset sep-
sis whereas hypothermia, chest indrawing, umbilical red-
ness and jaundice were significantly predictors in late
onset sepsis (Table 3).
About 28.5% of neonates with positive blood culture
died compared to only 8.6% of those with negative blood
culture p = 0.0001. Gram negative sepsis had higher mor-
tality than gram positive sepsis. Increased mortality was
also seen with sepsis due to ESBL and MRSA isolates
(Table 4). Mortality in early onset disease was 28(23.1%)
compared to 29(16.1%) in late onset disease (p = 0.089).
The outcome of neonates with sepsis caused by sensitive
isolates was relatively good, 80.8% of neonates with sensi-
tive isolates improved after 72 hrs of treatment compared
to 2.2% of those with resistant isolates (p = 0.0001). Over-
all a total of 77(74%) neonates with sensitive isolates sur-
vived compared to only 15 (33.3%) of those with resistant
isolates (Table 5).Kayange et al. BMC Pediatrics 2010, 10:39
http://www.biomedcentral.com/1471-2431/10/39
Page 4 of 9
Table 1: Background characteristics and positive blood culture among neonates with early and late onset neonatal sepsis
Parameter Early onset sepsis ≤ 72 hrs Late onset sepsis > 72 hrs
NC u l t u r e
positive
n(%)
P = Value N Culture positive
n(%)
P = Value
Sex
Female (161) 63 30 (47.6) 98 45 (45.9)
Male (139) 58 27 (46.6) 0.906 81 47 (58.0 0.107
Mode of delivery
C/S (75) 31 12 (38.7) 44 24 (55.8)
SVD (225) 90 45 (50.0) 0.277 135 68 (50.0) 0.313
Gestation age
28-32 (22) 10 7 (70.0) 12 8 (66.7)
33-36 (93) 34 14 (41.2) 59 34 (57.6)
34-41 (185) 77 36 (46.8) 0.274 108 50 (46.3) 0.206
Delivery place
Home (114) 38 15 (39.5) 76 30 (39.5)
Hospital (186) 83 42 (50.6) 0.255 103 62 (60.2) 0.006
Maternal fever
Yes (70) 31 17 (54.8) 39 26 (66.7)
No (230) 90 40 (44.4) 0.317 140 66 (47.1) 0.031
Meconium stain
Yes (91) 42 34 (81.0) 49 42 (85.7)
No (209) 79 23 (29.1) 0.0001 130 50 (38.5) 0.0001
PROM
Yes (89) 41 33 (80.5) 48 41 (85.4)
No (211) 80 24 (30.0) 0.0001 131 51 (38.9) 0.0001
Birth weight
1- 2.5 kg (97) 42 20 (47.6) 55 34 (61.8)
2.6 - 5 kg (203) 79 37 (46.8) 0.7 124 59 (46.8) 0.045
Discussion
This study at BMC neonatal unit shows the prevalence of
neonatal sepsis among neonates admitted during study
period is about 39%. These findings are consistent with
reports from other developing countries and those done
in other tertiary hospitals in Tanzania [9-11]; but higher
than those reported in developed countries [1]. The vari-
ations between developed countries and developing
countries are due to high quality of life and hospital ser-
vices in developed countries [1].
In this study the mortality rate of neonatal sepsis was
19% which is similar to that observed in other studies in
East Africa region [11,12]; this can be explained by rela-
tive similar management practices and similar hospital
services. Higher mortality rate was observed among neo-
nates with early onset disease although the differenceKayange et al. BMC Pediatrics 2010, 10:39
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observed was not statistically significant. Among children
suspected with neonatal sepsis using clinical criteria 49%
were confirmed to have septicemia and no significant dif-
ference was observed among neonates with early or late
onset sepsis. These findings are similar to those obtained
in other studies in Africa which have been found to range
from 25-54% [9,10,18]. When the findings are compared
to the study in Uganda [11] in which proven sepsis was
37% among 293 neonates, the difference could be
explained by stringent criteria used in the present study.
In the present study clinical characteristics such as
inability to feed, cyanosis, lethargy and convulsion were
found to be significantly associated with positive blood
culture (p < 0.05) in both early and late onset neonatal
sepsis, similar findings were observed in other studies
[11,19]. Hypothermia, maternal fever, umbilical redness
and jaundice were also found to be predictors of positive
blood culture only among neonates with late onset sepsis
whereas increased respiratory rate was significant predic-
tor of positive blood in early onset disease only. These
clinical signs and symptoms laid by WHO Young infants
study group [6] could be used in the areas of limited facil-
ities to predict positive blood culture and initiation of
proper empirical management.
As in other studies perinatal factors which were
strongly found to predict positive blood culture in both
early and late onset disease were PROM and meconium
stained liquor [19,20]. Of neonates with late onset disease
positive blood culture rate was significantly higher in
those delivered at hospital (p = 0.006). This could partly
be explained by type of organisms isolated, most of the
isolates in the present study were multiply resistant, pos-
sibly hospital acquired infections. Place of delivery had no
influence on positive blood culture among neonates with
early onset sepsis. There was no control group in the
present study and only neonates with blood culture
drawn were included in the analysis; this could have
caused selection bias in determining the predictors of
positive blood culture.
Organisms which were found significantly causing sep-
t i c a e m i a  i n  P R O M  w e r e  Escherichia coli,  Enterobacter
spp, Group B streptococci and Klebsiella pneumoniae (p <
0.05), this could be due to the ascending infection from
perineum and vagina. As in other studies [2,20,21] these
pathogens are commonly responsible for early onset dis-
ease and this was confirmed in the present study.
In contrast to other studies in developed countries [22],
gram negative bacteria formed majority of the isolates in
our study. Klebsiella pneumoniae was the commonest
isolate recovered in the present study. The predominance
of an organism causing septicemia in the unit can be due
to selective pressure of antibiotics, this has been found to
be true with neonatal septicemia due to Klebsiella pneu-
moniae [20]. In our study majority of Klebsiella pneumo-
niae  were resistant to multiple antibiotics with 49% of
these isolates producing extended spectrum beta-lacta-
Table 2: Isolates and resistance pattern of 149 isolates recovered from blood of 300 neonates
Drugs K. pneumoniae 
(50)
E. coli(22) *Other 
GNB(15)
S. aureus (32) CNS(14) *Other 
GPB(16)
Ampicillin 100% 100% 93% NT NT 50%
AMC 84% 86% 93% NT NT NT
SXT 79% 77% 80% 60% 60% NT
Tetracycline 62% 59% 93% NT NT NT
Gentamicin 67% 68% 66% NT NT 68%
Ceftriaxone 50% 50% 53% NT NT NT
Cefotaxime 49% 50% 53% NT NT NT
Ceftazidime 49% 50% 46% NT NT NT
Ciprofloxacin 8.2% 4.5% 13% 14% 17% 43%
Meropenem 2% 4.5% 0% NT NT NT
Vancomycin NA NA NA 14% 0% 0%
Erythromycin NA NA NA 66% 50% 75%
Penicillin NA NA NA 91% 86% 50%
Clindamycin NA NA NA 44% 29% 56%
Cloxacillin NA NA NA 28% 43% 62.5%
GNB: Gram negative bacteria, GPB: Gram positive bacteria, NA: Not applicable, NT: Note tested, SXT: Sulphamethaxazole/trimethoprim, AMC: 
Amoxicillin/Clavulanic acidKayange et al. BMC Pediatrics 2010, 10:39
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Table 3: Clinical characteristics and positive blood culture among early onset and late onset neonatal sepsis (N 300)
Parameter (N) Early onset sepsis ≤ 72 hrs Late onset sepsis > 72 hrs
N
(121)
Culture 
positive n (%)
P value N
(179)
Culture 
positive n (%)
P = Value
Temperature
< 36°C (68) 31 17 (55.0) 37 26 (70.3)
> 37.5°C (232) 90 40 (44.0) 0.214 142 66 (46.5) 0.008
Respiratory rate
30-60 b/m 
(141)
61 22 (36.1) 80 36 (45.0)
> 60 b/m (159) 60 35 (58.3) 0.011 99 56 (56.6) 0.82
Chest indrawing
Yes (174) 69 36 (52.2) 105 60 (57.1)
NO (126) 52 21 (40.4) 0.270 74 32 (43.8) 0.071
Umbilical redness
Yes (50) 20 11 (55.0) 30 21 (70.0)
NO (250) 101 46 (45.5) 0.298 149 71 (47.7) 0.020
Lethargy
Yes (119) 55 39 (71.0) 64 50 (78.0)
NO (143) 66 18 (27.3) 0.0001 115 42 (36.5) 0.0001
Unable to feed
Yes (263) 107 57 (53.3) 156 89 (57.1)
NO (37) 14 0 (0.0) 0.0001 23 3 (13.0) 0.0001
Cyanosis
Yes (78) 36 24 (66.7) 42 27 (64.3)
No (222) 85 33 (38.5) 0.004 137 65 (46.6) 0.041
Jaundice
Yes (54) 21 13 (62.0) 33 24 (73.0)
NO (246) 100 44 (44.0) 0.155 146 68 (46.0) 0.005
Convulsion
Yes (57) 24 20 (83.3) 33 25 (76.0)
NO (243) 97 37 (38.0) 0.0001 146 67 (46.0) 0.002
mases (ESBL). Escherichia coli were the second common-
est gram negative bacteria with majority of them causing
early neonatal sepsis and 45.5% were found to be ESBL
producer. About 68% of Klebsiella pneumoniae and
Escherichia coli isolates in the unit were resistant to gen-
tamicin and 90% resistant to ampicillin. This poses chal-
lenge in the use of these first line drugs in the
management of neonatal sepsis in our setting. In the unit
the second choice of treatment is third generation cepha-
losporins of which more than 49% of gram negative iso-
lates were found to be resistant. High resistance rate of
third generation cephalosporins can be contributed byKayange et al. BMC Pediatrics 2010, 10:39
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irrational use of these antibiotics in the unit; this can fur-
ther be supported by low resistance rate of ciprofloxacin,
the drug which is not commonly prescribed to neonates
and there is no pharmacokinetic information to guide
dosing of ciprofloxacin in infants [4,23]. About 95% of
gram negative enteric bacteria were sensitive to mero-
penem similar findings have been reported elsewhere
[23]. This drug is expensive and not available in many
centers in developing countries, this makes the manage-
ment of neonatal sepsis due to multi-resistant gram nega-
tive bacteria to be difficult in these countries.
Staphylococcus aureus was the second common isolate
in this study and the leading among gram positive iso-
lates. Staphylococcus aureus was significantly recovered
in neonates from mothers without PROM (p < 0.05) and
it was the commonest isolate in the late onset sepsis.
Table 4: Factors associated with increased neonatal deaths among neonates with neonatal sepsis
Parameter N Death (%) P value
Culture
Positive 149 28.5
Negative 151 8.6 0.0001
Gram reaction
Positive 58 19
Negative 91 36.3 0.0001
ESBL
Positive 36 52
Negative 55 25 0.008
MRSA
Positive 9 55
Negative 23 21 0.008
Table 5: Outcome of neonates with positive blood culture in relation to duration of treatment and sensitivity pattern
Duration of 
treatment
Improved/Discharged
N (%)
Critical conditions
N (%)
Died
N (%)
P = Value
24 hrs
Sensitive (104) 57 (54.8) 50 (45.2) 0 (0.0)
Resistant (45) 0 (0.0) 42 (93.3) 3 (6.7) p = 0.0001
48 hrs
Sensitive (104) 73 (70.2) 15 (14.4) 16 (15.4)
Resistant (45) 14 (31.1) 18 (40.0) 13 (28.9) P = 0.0001
72 hrs
Sensitive (104) 84 (80.8) 4 (3.8) 16 (15.4)
Resistant (45) 1 (2.2) 24 (53.3) 20 (44.5) p = 0.0001
> 72 hrs
Sensitive (104) 77 (74.0) - 27 (26.0)
Resistant (45) 15 (33.3) - 30 (66.7) P = 0.0001
The p value indicates the different in outcome among neonates treated with sensitive and those with resistant antibiotics.Kayange et al. BMC Pediatrics 2010, 10:39
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About 28.1% of Staphylococcus aureus were found to be
MRSA and about 91% resistant to penicillin, similar
observation was made by Mugalu et al [11]. The signifi-
cant association of late onset disease and Staphylococcus
aureus septicaemia (p = 0.008), could partly be explained
by the fact that these organisms are transferred to neo-
nates from health care workers and relatives. In contrast
to other studies [1,2], gram positive such as Group B
Streptococci and Listeria spp were not commonly iso-
lated in this study. Only two blood cultures were positive
for group B streptococci (1.3%) and these were found in
early onset sepsis. Listeria spp was isolated in 5 samples
of which 3 were from early onset sepsis.
Different factors were found to contribute to increased
mortality rate in the present study. As demonstrated in
previous studies the outcome of sepsis is usually deter-
mined by duration of inflammatory response to the
offending pathogens, with severe and worse outcome in
the gram negative sepsis [18,24]. Factors which were sig-
nificantly found to predict deaths in this study were being
blood culture positive, isolation of gram negative bacte-
ria, ESBL isolate and MRSA isolate. As in other studies
gram negative sepsis has been associated with severe sep-
sis and increased mortality [21,23] and this was con-
firmed in our study. Routine report of laboratory results
gram stain reaction could have significant influence in
the management and outcome of the neonatal sepsis in
our setting and other setting in developing countries.
High mortality rate was observed among neonates
infected with ESBL producing organisms in the present
study [21,23]. In this study as in other few studies no sig-
nificant difference was observed in mortality among neo-
nates with early or late onset sepsis [11,23,24]. Majority of
neonates with multi-resistant organisms died within 72
hrs of initiation of antimicrobials. Relative good survival
was demonstrated in neonates with sensitive organisms,
more than 80% of them improved after 72 hrs of treat-
ment, this has been reported elsewhere [23,25].
Currently there is no guideline to treat neonatal sepsis
due ESBL isolates in most centers in the developing coun-
tries. In this study high dose of gentamicin in combina-
tion with high dose of cefotaxime was used, and in some
cases ciprofloxacin was used. Survival rate was 47%
among 36 cases, survival was better with ciprofloxacin;
than cefotaxime+ gentamicin, twenty neonates survived
of which 13/20 (65%) received ciprofloxacin.
Conclusion
Neonatal sepsis is common in our setting and has high
mortality; convulsion, lethargy, inability to feed, cyanosis,
PROM and meconium stained liquor were significantly
found to predict positive blood culture in both early and
late onset neonatal sepsis. Mortality and morbidity of
neonatal sepsis is high in our setting and significantly
contributed by positive blood culture with multi-resistant
gram negative bacteria. Guidelines for management of
neonatal sepsis in developing countries are needed so
that morbidity and mortality of sepsis due to highly prev-
alent multi-resistant gram negative bacteria and MRSA
can be reduced.
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